Views

CrossRef citations to date

Altmetric

Original Articles: Clinical Oncology

Altered p53/p16 expression is linked to urothelial carcinoma progression but largely unrelated to prognosis in muscle-invasive tumors

Simon Schallenberga Institute of Pathology, Charité Berlin, Berlin, Germany

Henning Plageb Department of Urology, Charité Berlin, Berlin, Germany

Sebastian Hofbauerb Department of Urology, Charité Berlin, Berlin, Germany

Kira Furlanob Department of Urology, Charité Berlin, Berlin, Germany

Sarah Weinbergerb Department of Urology, Charité Berlin, Berlin, Germany

Paul Giacomo Bruchb Department of Urology, Charité Berlin, Berlin, Germany

Florian Roßnera Institute of Pathology, Charité Berlin, Berlin, Germany

Sefer Elezkurtaja Institute of Pathology, Charité Berlin, Berlin, Germany

Martina Kluthc Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Maximilian Lennartzc Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Niclas C. Blessinc Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Andreas H. Marxd Department of Pathology, Academic Hospital Fuerth, Fuerth, Germany

Henrik Samtlebend Department of Pathology, Academic Hospital Fuerth, Fuerth, Germany

Margit Fische Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Michael Rinkf Department of Urology, Marienhospital Hamburg, Hamburg, Germany

Marcin Slojewskig Department of Urology and Urological Oncology, Pomeranian Medical University, Szczecin, Poland

Krystian Kaczmarekg Department of Urology and Urological Oncology, Pomeranian Medical University, Szczecin, Poland

Thorsten Eckeh Department of Urology, Helios Hospital Bad Saarow, Bad Saarow, Germany

Steffen Hallmannh Department of Urology, Helios Hospital Bad Saarow, Bad Saarow, Germany

Stefan Kochi Department of Pathology, Helios Hospital Bad Saarow, Bad Saarow, Germany

Nico Adaminij Department of Urology, Albertinen Hospital, Hamburg, Germany

Sarah Minnerc Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Ronald Simonc Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyCorrespondence[email protected]

https://orcid.org/0000-0003-0158-4258

Guido Sauterc Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

David Horsta Institute of Pathology, Charité Berlin, Berlin, Germany

Tobias Klatteh Department of Urology, Helios Hospital Bad Saarow, Bad Saarow, Germany

Thorsten Schlommb Department of Urology, Charité Berlin, Berlin, Germany

Henrik Zechab Department of Urology, Charité Berlin, Berlin, Germany;j Department of Urology, Albertinen Hospital, Hamburg, Germany

show all

Altered p53/p16 expression is linked to urothelial carcinoma progression but largely unrelated to prognosis in muscle-invasive tumors

Supplemental Material

Supplemental Material

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Altered p53/p16 expression is linked to urothelial carcinoma progression but largely unrelated to prognosis in muscle-invasive tumors

Supplemental Material

Supplemental Material

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date